Certificate Reference
For continuity with the current catalog, this page links to laboratory documentation for a component or a closely related product. The linked certificate is a reference only and is not represented as the batch-specific COA for Retatrutide + Cagrilintide.
Overview
Retatrutide + Cagrilintide is an experimental combination that pairs triple GIP/GLP-1/glucagon receptor agonism with long-acting amylin-receptor agonism. The research rationale is complementary control of metabolic signaling, satiety-related pathways, glucose handling, and energy balance through receptor systems that are only partly overlapping.
Research Focus
WHAT THIS FORMULA FEATURES
Retatrutide provides incretin plus glucagon-receptor signaling, while cagrilintide adds an amylin pathway. Clinical research has established meaningful metabolic effects for retatrutide alone and for cagrilintide combined with semaglutide, but controlled published studies of this exact retatrutide+cagrilintide combination are not established; synergy should therefore be tested rather than assumed.
EXPECTED RESEARCH READOUTS
Useful endpoints include receptor-specific cAMP signaling, food intake, gastric/meal-response markers, insulin and glucagon, glucose excursions, body-weight/fat-mass changes in appropriate models, energy expenditure, and direct comparison against each component alone to identify additivity or synergy.
Research endpoints described above reflect published or model-based scientific observations and are not guaranteed outcomes. This product is strictly for research purposes only. Not approved for human or animal use.
Key Characteristics
MOLECULAR PROFILE
CAS: 2381089-83-2 | 1415456-99-3
Classification: Multi-component research blend
Composition: Retatrutide 5mg; Cagrilintide 5mg
PHYSICAL PROPERTIES
Form: Lyophilized powder
Catalog strengths: 10 mg
Purity specification: ≥99% catalog specification; verify current batch COA
Storage: Store at −20°C (−4°F) for long-term storage or 4°C (39°F) for short-term storage; avoid repeated freeze-thaw cycles.
Testing: Batch documentation should be verified against the current lot before analytical use.
